Rising Incidence of Skin Cancer Among Older Men as Global Population Ages

Skin cancer rates among older men are rising globally, driven by demographic shifts and increased ultraviolet exposure. Learn about recent research on this growing health concern and the importance of early detection and prevention.
As the world's population continues to age, the prevalence of skin cancer among older adults, especially men, is experiencing a notable increase. Recent research conducted by the First Affiliated Hospital of Chongqing Medical University in China highlights a significant rise in skin cancer cases driven largely by demographic shifts and population growth. Skin cancer, already among the most expensive cancers to treat, is becoming an even greater public health concern due to the cumulative effects of long-term ultraviolet exposure, which is more prevalent in older individuals.
A comprehensive study published in JAMA Dermatology, titled "Burden of Skin Cancer in Older Adults From 1990 to 2021 and Modelled Projection to 2050," analyzed data from the Global Burden of Diseases 2021 registry across 204 countries. The investigation estimated over 4.4 million new skin cancer cases in individuals aged 65 and above in 2021, with projections indicating further increases by 2050. The study focused on three main types: melanoma, squamous cell carcinoma, and basal cell carcinoma.
Findings show that from 1990 to 2021, the incidence of squamous cell carcinoma grew at an average rate of about 2% annually, effectively doubling over three decades. Basal cell carcinoma and melanoma also demonstrated consistent upward trends. The cumulative effect of these increases, combined with an expanding older population, resulted in millions more diagnoses and a higher burden of disease, measured through metrics like prevalence, deaths, and disability-adjusted life years (DALYs).
Men bore approximately twice the disease burden compared to women, with countries possessing higher socio-economic status reporting the most cases. The data revealed stark regional differences, with New Zealand and Australia registering the highest melanoma rates among those aged 65 and older, along with elevated prevalence, mortality, and DALYs. East Asia experienced rapid growth in basal cell carcinoma cases, with annual increases exceeding 6%.
The findings underscore that much of the rising burden relates to factors like population growth and prolonged sun exposure over a lifetime, emphasizing the importance of early detection, preventive measures, and public awareness. Experts warn that without targeted intervention, the incidence of keratinocyte cancers, such as basal and squamous cell carcinomas, is expected to keep climbing, although melanoma rates may stabilize or decline.
This escalating public health challenge highlights the need for policymakers, healthcare providers, and individuals to prioritize skin cancer prevention and early diagnosis efforts to mitigate the impact on aging populations worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Age and Disease Duration as Key Predictors of Chronic Kidney Disease Post-Stem Cell Transplant
New research identifies age and disease duration as key factors influencing the risk of chronic kidney disease after hematopoietic stem cell transplantation, highlighting the need for targeted long-term kidney health management.
Microglia Are the Key Players in Photoreceptor Damage Response in the Retina, Not Neutrophils
New research reveals that microglia, rather than neutrophils, are the primary immune cells responding to photoreceptor damage in the retina, offering insights into eye disease mechanisms and potential therapies.
The Role of Education and Social Factors in Rheumatic and Musculoskeletal Diseases
Emerging research emphasizes the critical role of social determinants like income and education in shaping outcomes for patients with rheumatic and musculoskeletal diseases. Findings from the EULAR 2025 congress reveal how these factors influence disease progression and mortality, highlighting the need for targeted interventions to promote health equity.
Inflammatory Bowel Disease May Speed Up Cognitive Decline in Dementia Patients
New research suggests that inflammatory bowel disease may accelerate cognitive decline in dementia patients, highlighting the importance of personalized treatment strategies. Discover more about this groundbreaking study identifying the gut-brain connection.



